Newsroom

Sorted by: Latest

-

Utz Brands, Inc. and Intersnack Group GmbH & Co. KG Announce Completion of Transaction to Take Utz Private

HANOVER, Pa. & DÜSSELDORF, Germany--(BUSINESS WIRE)--Utz Brands, Inc. (NYSE: UTZ) (“UBI” or the “Company”), a leading U.S. manufacturer of branded salty snacks, and Intersnack Group GmbH & Co. KG (“Intersnack Group” or “Intersnack”), a leading, multinational savory snack manufacturer, today announced the completion of the previously announced transaction pursuant to which Intersnack Group acquired all outstanding shares of Class A Common Stock of UBI for $14.25 per share, a premium of appro...
-

Canada MedLaser Opens First Alberta Clinic in Calgary on November 23

CALGARY, Alberta--(BUSINESS WIRE)--Canada MedLaser opens its first Alberta clinic in Calgary on Nov. 23, marking the Toronto-founded medical aesthetics brand's first expansion west....
-

Oconee Federal to Merge With Pee Dee Federal Savings Bank

SENECA, S.C. & MARION, S.C.--(BUSINESS WIRE)--Oconee Federal Financial Corp. (OTCQX: OFED) (the “Company”), the holding company for Oconee Federal Savings and Loan Association (“Oconee Federal”), and the majority-owned subsidiary of Oconee Federal, MHC (the “MHC”), and Pee Dee Federal Savings Bank (“Pee Dee”), a federally-chartered mutual savings bank, today announced the execution of an agreement pursuant to which Pee Dee will merge with and into Oconee Federal with Oconee Federal as the surviv...
-

75% of Brand Leaders Worry AI Assistants Could Steer Shoppers to Competitors, Recom Study Finds

DEERFIELD BEACH, Fla.--(BUSINESS WIRE)--Brand leaders overwhelmingly expect AI to change how shoppers find products, but few say they are ready, according to new research from Recom....
-

Epitech Group and Horus Pharma sign a global licensing agreement to develop adelmidrol in eye health

NICE, France--(BUSINESS WIRE)--Epitech Group S.p.A., an Italian biopharmaceutical firm specializing in neuro-inflammation, and Horus Pharma, a French laboratory specializing in ophthalmology, announce a global licensing agreement for adelmidrol, a molecule belonging to the ALIAmide family, developed by Epitech Group. This agreement grants Horus Pharma exclusive rights to develop and market adelmidrol for human ophthalmology and periocular dermatology applications. It aims to explore new approac...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-

Natixis Syndicate UK Regulatory Announcement:  Post-stabilisation Announcement

LONDON--(BUSINESS WIRE)--  Date: 20th November 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CNP Assurances Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 9th November 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulat...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-

Natixis Syndicate UK Regulatory Announcement: Post-Stabilisation Announcement

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 20th November 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Pernod Ricard Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 21st October 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2...
-

Mechanics Bancorp Declares Fourth Quarter 2026 Cash Dividend

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Mechanics Bancorp (Nasdaq: MCHB) today announced that its Board of Directors has declared a cash dividend of $0.43 per share of Class A common stock and $4.30 per share of Class B common stock, each payable on December 10, 2026, to shareholders of record as of the close of business on November 30, 2026.About Mechanics BancorpMechanics Bancorp is headquartered in Walnut Creek, Calif., and is the financial holding company of Mechanics Bank, a full-service, FD...